sameAs
Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert surveyEfficacy of antimanic treatments: meta-analysis of randomized, controlled trialsCognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analysesBipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlatesThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelinesThe International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future ResearchThe International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of GuidelinesClinical factors associated with treatment noncompliance in euthymic bipolar patientsPolarity index of pharmacological agents used for maintenance treatment of bipolar disorderA bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 yearsCognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting reportOnline information seeking by patients with bipolar disorder: results from an international multisite surveySystematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses.Sudden glory revisited: cognitive contents of hypomania.Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data).The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disordersLongitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence.Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis.A systematic literature review of resting state network--functional MRI in bipolar disorder.Structural abnormalities in bipolar euthymia: a multicontrast molecular diffusion imaging study.Latest maintenance data on lamotrigine in bipolar disorder.Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial.Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.Big Data in mental health: a challenging fragmented future.Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina.The somatics of psyche: structural neuromorphometry of bipolar disorder.A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.Self-monitoring and psychoeducation in bipolar patients with a smart-phone application (SIMPLe) project: design, development and studies protocolsInternet-based psychological interventions for bipolar disorder: Review of the present and insights into the future.Psychoeducation in bipolar disorder with a SIMPLe smartphone application: Feasibility, acceptability and satisfaction.Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder?Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysisEffectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.Evidence and implications for early intervention in bipolar disorder.The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.
P50
Q24273410-C73B7236-8AC9-44A4-9704-EF9FD5E660DEQ24601815-17964095-530C-4B9B-91B5-63BC0A07DBD6Q26771515-9361E426-CC5A-4736-AC01-693CC77E3BBEQ27025413-23758370-62F1-4034-A743-4154FC630B0AQ28066714-81B1C2F1-C0B1-4B4D-A766-9EF3945858D7Q28069743-2110B2FF-6101-401D-A4CB-42CE886365C6Q28072601-D5264225-1B67-4855-9BB8-8D1332AAF673Q28076486-A3F800FD-9DCC-46B2-8605-373189D5C7DFQ28138392-F3BF17DF-4933-4852-B5F0-DF4305F69226Q28250466-041AD02E-F2B6-4D37-A31B-25A515488186Q28276418-A5A4D58C-9F26-434B-BE52-813DAAACF8CAQ28291786-EA7CC56D-B6F5-4DA7-A23E-E15AF0F38F26Q28597389-A682956A-FE38-4AC3-AD42-C63D651EFFDDQ30234571-441D33FD-B0CF-4D1F-BB23-7DB83C7B9D38Q30363434-F9AE60F4-740F-49B4-839D-06F0A93CE5A7Q30559418-BD8838E1-74C0-47A4-B1CE-B8C8BC2B5E59Q30583384-E274CA35-232F-4B3A-8BD1-2FF2688D48B5Q30585988-E0B53856-D434-418E-A655-7496BD791671Q30619862-0A03036A-13C3-4DB2-935E-1BCAA3D111C1Q30653685-398113F8-DD92-4FD1-836A-A3530B600415Q30690246-6BE29E33-A273-42BD-8E00-80B27E51CD48Q30823309-6AB144AB-4441-4D72-B9CE-82988796CCA9Q30843923-3DC0F06D-23FE-4EE9-A01B-D550C913637BQ30970834-BBA6184B-008A-4DB7-9AE9-148156D6E0F2Q30999127-38AB7134-AD1C-4617-B4AA-6538929B22B8Q31105813-96F9CC83-F645-485B-98C2-B24430136655Q31127921-3391DC02-76A6-48BA-ADBC-80D8FA9E80B2Q31399132-D64EDAEF-5C44-46C7-8E8F-DF9FAA08E137Q32148738-965D96CC-6460-45EA-BE32-945DF02DFC6CQ33284843-39A8EF05-5D1C-4D38-BFCA-7214BACD3E6AQ33364302-963C3A42-D113-44B7-A55A-DA4093FF7A76Q33443296-7F56C519-0CBE-4DDA-A62D-EB44A428B253Q33444992-B440FC83-1C16-4CA5-BA2B-A45959C70323Q33448472-8EF5AAD9-9B8F-4315-BFAF-0F78F775C64AQ33455598-FD1AB59D-0627-4D9F-A939-D555265FC2B8Q33518859-463657EB-13D2-4489-B1D3-FA23D15CC39BQ33529314-CB7474CA-A9FC-44ED-8661-AFB693F7F0E3Q33553208-D8E9ADCA-AE4A-4720-A86B-0AAC06090A72Q33568997-201BA0B2-D5CA-4EE2-860E-485DFAFA1F45Q33605308-6535FCF2-DD22-4448-B4BB-31A31CA0921D
P50
description
Spaans psychiater
@nl
Spanish psychiatrist
@en
psichiatra spagnolo
@it
psikiatra espainiarra
@eu
psiquiatra espanhol
@pt
psiquiatra español
@ast
psiquiatra español
@es
psiquiatra español
@gl
psiquiatre espanyol
@ca
psychiatre espagnol
@fr
name
Eduard Vieta Pascual
@ca
Eduard Vieta
@en
Eduard Vieta
@es
Eduard Vieta
@fr
Eduard Vieta
@ga
Eduard Vieta
@nl
Eduard Vieta
@sl
Eduard Vieta
@sq
type
label
Eduard Vieta Pascual
@ca
Eduard Vieta
@en
Eduard Vieta
@es
Eduard Vieta
@fr
Eduard Vieta
@ga
Eduard Vieta
@nl
Eduard Vieta
@sl
Eduard Vieta
@sq
prefLabel
Eduard Vieta Pascual
@ca
Eduard Vieta
@en
Eduard Vieta
@es
Eduard Vieta
@fr
Eduard Vieta
@ga
Eduard Vieta
@nl
Eduard Vieta
@sl
Eduard Vieta
@sq
P1153
P214
P227
P244
P268
P269
P349
P950
P1053
I-6330-2013
P106
P1153
34573729100
57202561201
7006850485